iDtheinvestordatabase
Home / Directory / ShangBay Capital
Likely active: new deal Jan 2025 Verified 5 Nov 2026

ShangBay Capital

Palo Alto venture firm making early-stage equity investments mainly in US medical device, biotech and healthcare technology companies.

Type
VC firm
Location
Palo Alto, California, United States
Stages
Seed
Backs
Medtech and digital health, Biotech and pharma
Sectors
Healthtech and life sciences, Biotech
Fund size / AUM
$48.2M ShangBay Capital III (Form D amount sold, 2021); $262.3M gross private fund assets (Form ADV; private funds: 6, of which venture capital: 6)
Latest fund or filing
6 Jan 2022
Portfolio mix
Medtech and digital health 59%; Biotech and pharma 32%; B2B software 7%; Hardware 2% (n=29)

Contacts on file

For ShangBay Capital, the paid file holds: 7 named decision-makers with roles; LinkedIn page.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

CeribellLucira HealthApexigenBerkeley LightsNeurovasc

Sources

Last checked 5 Nov 2026. Is something wrong? Tell us.

Appears in 30 lists